Evotec SE’s Chief Business Officer, Dr. Matthias Evers, has decided to step down to pursue opportunities outside of Evotec. He will depart the company effective October 1, 2024.
 
Dr. Evers, Chief Business Officer of Evotec SE, commented: “Thank you to my amazing colleagues across all of Evotec – the passion for medicines that matter is inspiring and the people at Evotec make all the difference. While I have chosen to pursue a new path, I wish Evotec with all colleagues long-term success which I am confident the priority reset will bring.”
 
Dr Christian Wojczewski, CEO of Evotec, added: “On behalf of the Management Board, I would like to thank Matthias for his commitment and dedication to Evotec for the past two-and-a-half years. He has shown great leadership in challenging times and his contributions will have lasting impact. On a personal note, I would like to thank Matthias for the great onboarding and his ongoing support as his responsibilities transition to other Management Board members.”
 
As of October 1, the responsibilities of the CBO function will be distributed across the other Management Board functions.

More Evotec News